Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Doshi · SciRah

Researcher profile · Semantic Scholar

A. Doshi

Share profile

A. Doshi — researcher profile on SciRah

h-index: 14
Works: 50
Citations: 904

Most-cited papers

Multiple sclerosis, a treatable disease.
A. Doshi, J. Chataway
2016Clinical medicine (London)205 citations Open access
Semantic Scholar
Plasma melatonin is reduced in Huntington's disease
E. Kalliolia, E. Silajdžić, R. Nambron, N. Hill +6 more
2014Movement Disorders115 citations Open access
Semantic Scholar
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
J. Chataway, F. De Angelis, P. Connick, R. Parker +49 more
2020Lancet Neurology112 citations Open access
Semantic Scholar
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis
A. Calvi, F. P. Carrasco, C. Tur, D. Chard +11 more
2022Neurology63 citations Open access
Semantic Scholar
Multiple sclerosis, a treatable disease
A. Doshi, J. Chataway
2016Clinical medicine (London)62 citations Open access
Semantic Scholar
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
P. Connick, F. De Angelis, R. Parker, D. Plantone +20 more
2018BMJ Open52 citations Open access
Semantic Scholar
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial
Thomas Williams, C. Tur, A. Eshaghi, A. Doshi +6 more
2022Multiple Sclerosis46 citations Open access
Semantic Scholar
A Systematic Review of Resting-State Functional MRI Connectivity Changes and Cognitive Impairment in Multiple Sclerosis
D. Jandric, A. Doshi, R. Scott, D. Paling +5 more
2021medRxiv37 citations Open access
Semantic Scholar
Secondary Progressive Multiple Sclerosis: Definition and Measurement
D. Plantone, F. De Angelis, A. Doshi, J. Chataway
2016CNS Drugs36 citations Open access
Semantic Scholar
Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance
Waqar Rashid, O. Ciccarelli, Siobhan M. Leary, T. Arun +9 more
2024Practical Neurology25 citations
Semantic Scholar
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
J. Blackstone, Thomas Williams, Jennifer M Nicholas, Ekaterina Bordea +58 more
2024BMJ Open18 citations Open access
Semantic Scholar
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT
F. De Angelis, P. Connick, R. Parker, D. Plantone +24 more
2020Efficacy and Mechanism Evaluation16 citations Open access
Semantic Scholar
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study
B. S. Solanky, N. John, F. DeAngelis, J. Stutters +12 more
2020American Journal of Neuroradiology14 citations Open access
Semantic Scholar
Just a graze? Cephalic tetanus presenting as a stroke mimic
A. Doshi, Clare E. Warrell, D. Dahdaleh, D. Kullmann
2013Practical Neurology14 citations
Semantic Scholar
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial
T. Williams, N. John, A. Calvi, A. Bianchi +16 more
2023European Journal of Neurology12 citations Open access
Semantic Scholar
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
J. Chataway, Thomas Williams, J. Blackstone, N. John +59 more
2025The Lancet11 citations Open access
Semantic Scholar
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments
N. John, B. Solanky, F. De Angelis, R. Parker +14 more
2023Journal of Magnetic Resonance Imaging11 citations Open access
Semantic Scholar
ECTRIMS 2024 – Late Breaking Oral Presentations
A. Abdelhak, A. Maceski, S. Schädelin, Eline Willemse +191 more
2024Multiple Sclerosis9 citations
Semantic Scholar
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial
F. De Angelis, James R. Cameron, A. Eshaghi, R. Parker +13 more
2024Journal of Neurology Neurosurgery & Psychiatry6 citations Open access
Semantic Scholar
The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK.
Linford Fernandes, C. Allen, T. Williams, E. Tallantyre +39 more
2021Multiple Sclerosis and Related Disorders6 citations Open access
Semantic Scholar
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis
N. John, Yingtong Li, F. De Angelis, J. Stutters +9 more
2024European Journal of Neurology5 citations Open access
Semantic Scholar
Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials
T. Williams, Sarah Alexander, J. Blackstone, F. De Angelis +6 more
2022Trials5 citations Open access
Semantic Scholar
An unusual bump on the head. Intraextracranial meningioma presenting incidentally
V. Nadarajan, J. Goddin, Dina Luder, A. Doshi
2012BMJ Case Reports5 citations Open access
Semantic Scholar
Neurofilament heavy chain in secondary progressive multiple sclerosis
F. De Angelis, F. Ammoscato, R. Parker, D. Plantone +11 more
2025Multiple Sclerosis4 citations Open access
Semantic Scholar
The practical uses of serum neurofilament light chain as a biomarker in multiple sclerosis.
J. Coker, A. Doshi, S. Gnanapavan
2025Multiple Sclerosis and Related Disorders4 citations
Semantic Scholar
Brain reserve and physical disability in secondary progressive multiple sclerosis
N. John, Yingtong Li, F. De Angelis, J. Stutters +48 more
2024BMJ Neurology Open3 citations Open access
Semantic Scholar
The ABILHAND‐23 Patient Reported Outcome Measure in Secondary Progressive Multiple Sclerosis: A Cross‐Sectional Analysis With the Nine Hole Peg Test
Sean Apap Mangion, Charles Wade, T. Williams, A. Bianchi +14 more
2025Brain and Behavior2 citations Open access
Semantic Scholar
Optical coherence tomography in secondary progressive multiple sclerosis: a baseline data report from the MS-SMART trial
F. De Angelis, James R. Cameron, P. Connick, Dh Miller +14 more
20162 citations
Semantic Scholar
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple Sclerosis
N. John, Yingtong Li, F. De Angelis, F. Carrasco +7 more
2026European Journal of Neurology1 citations Open access
Semantic Scholar
Investigating the impact of different dichotomous definitions for cognitive impairment on functional connectivity in secondary progressive MS.
A. Doshi, Nils Muhlert, G. Castellazzi, Adnan A. S. Alahmadi +8 more
2025Multiple Sclerosis and Related Disorders1 citations Open access
Semantic Scholar
180 Cognitive diagnostic criteria lead to distinct patterns of functional connectivity in secondary progressive MS
A. Doshi, G. Castellazzi, N. Muhlert, Adnan A. S. Alahmadi +4 more
2019Journal of Neurology Neurosurgery & Psychiatry1 citations Open access
Semantic Scholar
Initial cross-sectional MR spectroscopy analysis of a cohort of secondary progressive MS patients enrolled in the MS-SMART trial
D. Plantone, B. Solanky, S. Pavitt, G. Giovannoni +11 more
20161 citations
Semantic Scholar
Isolated Atraumatic Injury of the Supraspinous and Interspinous Ligaments
V. Joshi, A. Casden, B. Skovrlj, A. Doshi
20151 citations
Semantic Scholar
Back pain and acute kidney injury.
A. Doshi, M. Khosravi, D. Marks, M. Rodríguez-Justo +2 more
2013Clinical medicine (London)1 citations Open access
Semantic Scholar
Optimal Clinical Trials Platform for Progressive Multiple Sclerosis (OCTOPUS): protocol for an international, multi-arm, multi-stage, platform, randomized controlled, double-blind, phase 3 clinical trial.
S. Apap Mangion, C. Wade, C. Pugh, M. Burnell +42 more
2026medRxiv0 citations Open access
Semantic Scholar
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
Thomas Williams, J. Blackstone, N. John, M. Braisher +57 more
2026Health Technology Assessment0 citations Open access
Semantic Scholar
Executive Dysfunction and Disability in SPMS: Predictive Value of the Frontal Assessment Battery in the UCLH MS‐STAT2 Cohort
Charles Wade, A. Doshi, S. Mangion, T. Williams +9 more
2025European Journal of Neurology0 citations Open access
Semantic Scholar
Adult inflammatory leukoencephalopathies.
Thomas Williams, N. John, A. Doshi, J. Chataway
2024Handbook of Clinical Neurology0 citations
Semantic Scholar
MS-SMART study: systematic sampling bias concerns - Authors' reply.
J. Chataway, F. De Angelis, P. Connick, R. Parker +6 more
2020Lancet Neurology0 citations Open access
Semantic Scholar
Dimethyl fumarate may still have a role in progressive multiple sclerosis
D. Plantone, F. De Angelis, A. Doshi, J. Chataway
2016Therapeutic Advances in Neurological Disorders0 citations Open access
Semantic Scholar
Faculty of 1000 evaluation for Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care.
J. Chataway, A. Doshi
20160 citations Open access
Semantic Scholar
TREATMENT OF ATYPICAL CNS INFLAMMATION WITH MITOXANTRONE
R. Dobson, A. Doshi, L. Massey, Louise Crowe +6 more
2014Journal of Neurology Neurosurgery & Psychiatry0 citations Open access
Semantic Scholar
QUALITY IMPROVEMENT PROJECT: DETECTING, INSTIGATING AND ASSESSING EFFECTIVE HANDOVER TECHNIQUES
Clare E. Warrell, A. Doshi, Joseph Mayhew, Eve Thacker +4 more
2013Journal of Neurology Neurosurgery & Psychiatry0 citations
Semantic Scholar
Increasing awareness of eGFR monitoring.
Vivienne S Gould, Mahnaz Hashmi, N. Amin, A. Doshi
2009The British journal of psychiatry : the journal of mental science0 citations Open access
Semantic Scholar
CRANIAL NERVE DYSFUNCTIONS AMONG SURVIVORS OF TRAUMATIC BRAIN INJURY CAUSED BY VIOLENT AND NONVIOLENT INJURY
B. Giap, R. Zafonte, S. Millis, Cynthia Harrison-Felix +3 more
19990 citations
Semantic Scholar
BRACHIAL PLEXOPATHY AMONG SURVIVORS OF TRAUMATIC BRAIN INJURY CAUSED BY VIOLENT AND NONVIOLENT INJURY
B. Giap, R. Zafonte, S. Millis, Cynthia Harrison-Felix +3 more
19990 citations
Semantic Scholar
Cardiovascular risk factors in secondary progressive multiple Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross ‐ sectional analysis from the MS ‐ STAT2 sclerosis: A cross sectional analysis from the MS STAT2 randomized controlled trial randomized controlled trial
Thomas Williams, N. John, A. Calvi, A. Bianchi +16 more
0 citations
Semantic Scholar
PEARL Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐ sectional analysis from the <scp>MS‐STAT2</scp> randomized controlled trial
Thomas Williams, N. John, Alberto Calvi, A. Bianchi +16 more
0 citations
Semantic Scholar
Spectroscopic Imaging Study Secondary-Progressive MS: A Proton MR NAA is a Marker of Disability in
B. Solanky, N. John, F. DeAngelis, J. Stutters +12 more
0 citations
Semantic Scholar
Efficacy of three neuroprotective drugs in secondary progressive Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial blind,
J. Chataway, Angelis de, P. Connick, R. Parker +80 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. De Angelis×28
Invite
F. De Angelis — researcher profile on SciRah
N. John×25
Invite
N. John — researcher profile on SciRah
D. Plantone×17
Invite
D. Plantone — researcher profile on SciRah
J. Chataway×16
Invite
J. Chataway — researcher profile on SciRah

×16

Invite

J. Chataway — researcher profile on SciRah

Thomas Williams×16

Invite

Thomas Williams — researcher profile on SciRah

J. Stutters×13

Invite

J. Stutters — researcher profile on SciRah

M. Braisher×13

Invite

M. Braisher — researcher profile on SciRah

J. Blackstone×10

Invite

J. Blackstone — researcher profile on SciRah

Invite

D. MacManus — researcher profile on SciRah

Invite

A. Calvi — researcher profile on SciRah

Invite

P. Connick — researcher profile on SciRah